User:Mr. Ibrahem/Indinavir
Clinical data | |
---|---|
Trade names | Crixivan |
Other names | Indinavir sulfate |
AHFS/Drugs.com | Monograph |
MedlinePlus | a696028 |
License data | |
Routes of administration | By mouth |
Drug class | Protease inhibitor[1] |
Pharmacokinetic data | |
Bioavailability | ~65% |
Protein binding | 60% |
Metabolism | Liver via CYP3A4 |
Elimination half-life | 1.8 ± 0.4 hours |
Identifiers | |
| |
Chemical and physical data | |
Formula | C36H47N5O4 |
Molar mass | 613.803 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Indinavir (IDV), sold under the brand name Crixivan, is a medication used to treat HIV/AIDS together with other medications.[1] It is not a first line treatment.[1] It is taken by mouth.[1]
Common side effects include nausea, abdominal pain, headache, and kidney stones.[1] Other side effects may include liver problems, diabetes, and body fat redistribution.[1] Safety in pregnancy is unclear.[2] It is a protease inhibitor.[1]
Indinavir was patented in 1991 and approved for medical use in the United States and Europe in 1996.[3][1][4] In the United States it costs about 450 USD per month as of 2021.[5]
References[edit]
- ^ a b c d e f g h i j k "Indinavir Monograph for Professionals". Drugs.com. Archived from the original on 24 August 2021. Retrieved 26 November 2021.
- ^ "Indinavir (Crixivan) Use During Pregnancy". Drugs.com. Archived from the original on 28 November 2020. Retrieved 26 November 2021.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 509. ISBN 9783527607495. Archived from the original on 2021-06-20. Retrieved 2021-08-05.
- ^ "Crixivan". Archived from the original on 15 April 2021. Retrieved 26 November 2021.
- ^ "Indinavir Sulfate Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 26 November 2021.